Wong DA, Fornasier VL, MacNab I (1990) Spinal metastases: the obvious, the occult, and the impostors. Spine (Phila Pa 1976) 15(1):1–4

Article  CAS  PubMed  Google Scholar 

Hernandez RK, Wade SW, Reich A et al (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer 18(1):44

Article  PubMed  PubMed Central  Google Scholar 

Barzilai O, Laufer I, Yamada Y et al (2017) Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease. J Clin Oncol 35(21):2419–2427

Article  CAS  PubMed  Google Scholar 

Newman WC, Laufer I, Bilsky MH, Neurologic (2020) Oncologic, Mechanical, and systemic and other decision frameworks for spinal disease. Neurosurg Clin N Am 31(2):151–166

Article  PubMed  Google Scholar 

Debela DT, Muzazu SG, Heraro KD et al (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034366

Article  PubMed  PubMed Central  Google Scholar 

Palma DA, Olson R, Harrow S et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol 38(25):2830–2838

Article  PubMed  PubMed Central  Google Scholar 

Hall WA, Stapleford LJ, Hadjipanayis CG et al (2011) Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol 2011:979214

PubMed  PubMed Central  Google Scholar 

Gerszten PC, Burton SA, Ozhasoglu C et al (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32(2):193–199

Article  PubMed  Google Scholar 

Chang EL, Shiu AS, Mendel E et al (2007) Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151–160

Article  PubMed  Google Scholar 

Ryu S, Pugh SL, Gerszten PC,et al. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol 2014;4(2):76–81. https://doi.org/10.1016/j.prro.2013.05.001

Article  PubMed  Google Scholar 

Laufer I, Rubin DG, Lis E et al (2013) The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 18(6):744–751

Article  PubMed  PubMed Central  Google Scholar 

Yamada Y, Bilsky MH, Lovelock DM et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490

Article  PubMed  Google Scholar 

Aljabab S, Vellayappan B, Vandervoort E et al (2018) Comparison of four techniques for spine stereotactic body radiotherapy: dosimetric and efficiency analysis. J Appl Clin Med Phys 19(2):160–167

Article  PubMed  PubMed Central  Google Scholar 

PCG SAB (2005) Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 3:288–295

Article  Google Scholar 

von Baeyer CL, Spagrud LJ, McCormick JC et al (2009) Three new datasets supporting use of the numerical rating scale (NRS-11) for children’s self-reports of pain intensity. Pain 143(3):223–227

Article  Google Scholar 

Common Terminology Criteria for Adverse Events (CTCAE) (2017) 155. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ CTCAE_v5_Quick_Reference_5x7.pdf. Accessed June 2020

Thibault I, Al-Omair A, Masucci GL et al (2014) Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. J Neurosurg Spine 21(5):711–718

Article  PubMed  Google Scholar 

Farrar JT, Young JP Jr, LaMoreaux L et al (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149–158

Article  PubMed  Google Scholar 

Dworkin RH, Turk DC, Wyrwich KW et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9(2):105–121

Article  PubMed  Google Scholar 

Anand AK, Venkadamanickam G, Punnakal AU et al (2015) Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension. Clin Oncol (R Coll Radiol) 27(6):345–352

Article  CAS  PubMed  Google Scholar 

Yoo GS, Park HC, Yu JI et al (2017) Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture. Oncotarget 8(42):72860–72871

Article  PubMed  PubMed Central  Google Scholar 

Hariri O, Takayanagi A, Lischalk J et al (2019) Clinical efficacy of frameless stereotactic radiosurgery in the management of spinal metastases from thyroid carcinoma. Spine (Phila Pa 1976) 44(20):E1188–E1195

Article  PubMed  Google Scholar 

Mok T, Nakagawa K, Park K et al (2024) Nivolumab plus chemotherapy in epidermal growth factor receptor-mutated metastatic non-small-cell lung cancer after disease progression on epidermal growth factor receptor tyrosine kinase inhibitors: final results of checkmate 722. J Clin Oncol 42(11):1252–1264

Article  CAS  PubMed  Google Scholar 

Weitao Y, Zhihuang L, Liangyu G et al (2022) Surgical efficacy and prognosis of 54 cases of spinal metastases from breast cancer. World Neurosurg 165:e373–e379

Article  PubMed  Google Scholar 

Bollen L, van der Linden YM et al (2014) Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients. Neuro Oncol 16(7):991–998

Article  PubMed  PubMed Central  Google Scholar 

Sahgal A, Weinberg V, Ma L et al (2013) Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys 85(2):341–347

Article  PubMed  Google Scholar 

Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756–760

Article  CAS  PubMed  Google Scholar 

Chou KN, Park DJ, Hori YS et al (2024) Primary stereotactic body radiotherapy for spinal bone metastases from lung adenocarcinoma. Clin Lung Cancer 25(7):e337–e347

Article  PubMed  Google Scholar 

Sahgal A, Myrehaug SD, Siva S et al (2021) Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol 22(7):1023–1033

Article  PubMed  Google Scholar 

Tseng CL, Eppinga W, Charest-Morin R et al (2017) Spine stereotactic body radiotherapy: indications, outcomes, and points of caution. Glob Spine J 7(2):179–197

Article  Google Scholar 

Acar H, Yazici O, Unal D. Dosimetric comparison of robotic- and LINAC-based treatment of spine stereotactic body radiotherapy. Med Dosim 2022;47(4):348–355. https://doi.org/10.1016/j.meddos.2022.08.002

Sandhu N, Benson KRK, Kumar KA et al (2020) Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin. J Neurosurg Spine 33(1):87–94

Article  PubMed  Google Scholar 

Xu G, Zhou L (2024) ALK fusion small cell transformation of lung adenocarcinoma: A case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban 49(4):628–636 English, Chinese

CAS  PubMed  Google Scholar 

Fisher CG, DiPaola CP, Ryken TC et al (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the spine oncology study group. Spine (Phila Pa 1976) 35(22):E1221–E1229

Article  PubMed  Google Scholar